Szpak, Veronica
Velez, Andrea
Prostko, Sara
Rosenblum, Naomi
Maurer, Rie
Aguiar, Lyndon J.
Weiss, Roger D.
Suzuki, Joji
Funding for this research was provided by:
National Institute on Drug Abuse (R21DA056799)
Article History
Received: 18 April 2025
Accepted: 14 July 2025
First Online: 1 August 2025
Change Date: 28 August 2025
Change Type: Update
Change Details: The country name in the third affiliation has been corrected.
Declarations
:
: The study was approved by the Mass General Brigham (MGB) IRB. Participants signed an informed consent form and were provided with a copy.
: Not applicable.
: Dr. Weiss reports consultation with Alkermes and Eli Lilly and Company. All other authors report no conflicts of interest. The authors alone are responsible for the content and writing of this paper.
: NCT05817825.